Novo Nordisk | NVO - درآمد خالص

قیمت سهام
37.61
تغییر روزانه
0.70 1.90%
ماهیانه
-5.43%
سالیانه
-42.25%
Q2 پیش بینی
35.05




درآمد خالص تغییر دادن تاریخ
ANI Pharmaceuticals USD 32.35M 6.08M 2025-12
Aurora Cannabis CAD 1.82M 53.29M 2025-12
Bausch Health Companies USD -112M 291M 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Canopy Growth CAD -62.63M 60.99M 2025-12
Corcept Therapeutics USD 24.29M 4.62M 2025-12
Drreddys Laboratories INR 12.1B 2.08B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Merck USD 2.96B 2.82B 2025-12
Nektar Therapeutics USD -36.08M 978K 2025-12
Novartis USD 2.41B 1.52B 2025-12
Novo Nordisk DKK 26.89B 388M 2025-12
Novo Nordisk DKK 4.03B 25.01B 2025-06
Pacira USD 1.64M 3.8M 2025-12
Perrigo USD -1.42B 1.43B 2025-12
Phibro Animal Health USD 27.46M 932K 2025-12
Prestige Brands USD 46.7M 22.44M 2025-12
Sanofi EUR -801M 3.6B 2025-12
Supernus Pharmaceuticals USD -45.12M 67.62M 2025-09
Zoetis USD 603M 118M 2025-12